3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Liver Neoplasms
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Interventions
Sorafenib
22
Bevacizumab
15
pembrolizumab
10
durvalumab
7
Nivolumab
7
Ipilimumab
6
Drug Therapy
6
atezolizumab
5
Talaporfin
5
spartalizumab
4
regorafenib
4
lenvatinib
4
derazantinib
3
Ramucirumab
3
Photochemotherapy
3
Leucovorin
3
Injections
3
Fluorouracil
3
Doxorubicin
3
tremelimumab
2
toripalimab
2
seocalcitol
2
relatlimab
2
phosphomannopentaose sulfate
2
liposomal doxorubicin
2
exatecan
2
cabozantinib
2
brivanib
2
Phototherapy
2
Oxaliplatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Liver Neoplasms
×
Technetium Tc 99m Aggregated Albumin
×
Clear all
NCT05848947
2025-01-29
MAApping
Sirtex Medical
Phase 4
Completed
5 enrolled
9 charts